Outlook Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Sukhtian Ghiath M. | — | Award / Grant | 4,285,714 | $1.40 | $6,000,000 | 13,552,359 | May 27, 2025 |
| Sukhtian Ghiath M. | — | Option Exercise | 3,458,571 | $2.51 | $8,681,013 | 9,266,645 | Jan 17, 2025 |
| KENYON LAWRENCE A | Chief Financial Officer | Purchase | 5,000 | $5.69 | $28,450 | 5,946 | Sep 26, 2024 |
| Syntone Ventures LLC | — | Purchase | 714,286 | — | — | 1,705,438 | Apr 15, 2024 |
| Haddadin Yezan Munther | — | Purchase | 1,882 | $11.82 | $22,242 | 5,049 | Mar 28, 2024 |
| Sukhtian Ghiath M. | — | Award / Grant | 2,305,714 | — | — | 5,808,074 | Mar 18, 2024 |
| Evanson Jeff | CHIEF COMMERCIAL OFFICER | Purchase | 62,484 | $0.42 | $26,243 | 808,459 | Mar 7, 2024 |
| Dagnon Terry | Chief Operations Officer | Sale | 520,000 | $1.14 | $592,800 | 653,058 | Apr 20, 2023 |
| Evanson Jeff | Chief Commercial Officer | Sale | 267,000 | $1.11 | $296,370 | 745,975 | Jan 20, 2023 |
| Evanson Jeff | Chief Commercial Officer | Sale | 27,162 | $1.31 | $35,582 | 1,149,968 | Jan 18, 2023 |
| Sukhtian Ghiath M. | — | Award / Grant | 14,230,418 | $0.88 | $12,522,768 | 70,047,204 | Dec 28, 2022 |
| Sukhtian Faisal Ghiath | — | Purchase | 30,000 | $1.29 | $38,700 | 68,000 | Oct 7, 2022 |
| Haddadin Yezan Munther | — | Purchase | 29,743 | $1.29 | $38,368 | 59,743 | Oct 7, 2022 |
| HILZINGER KURT J | — | Purchase | 15,662 | $1.23 | $19,264 | 473,117 | Oct 4, 2022 |
| HILZINGER KURT J | — | Purchase | 13,800 | $1.19 | $16,422 | 286,917 | Sep 30, 2022 |
| Dagnon Terry | Chief Operating Officer | Purchase | 10,000 | $1.05 | $10,500 | 1,173,058 | Jun 21, 2022 |
| TRENARY C RUSSELL III | CEO and President | Purchase | 19,925 | $1.06 | $21,121 | 54,925 | Jun 21, 2022 |
| GMS Ventures & Investments | — | Other | 27,982,529 | — | — | 55,816,786 | Apr 21, 2022 |
| BioLexis Pte Ltd. | — | Other | 27,982,529 | — | — | 22,982,529 | Apr 21, 2022 |
| Sukhtian Ghiath M. | — | Other | 27,982,529 | — | — | 55,816,786 | Apr 21, 2022 |
| HILZINGER KURT J | — | Purchase | 27,708 | $1.69 | $46,827 | 273,117 | Mar 1, 2022 |
| HILZINGER KURT J | — | Purchase | 6,000 | $1.60 | $9,600 | 245,409 | Feb 24, 2022 |
| HILZINGER KURT J | — | Purchase | 95,597 | $1.49 | $142,440 | 118,714 | Feb 23, 2022 |
| Pillai Arun Kumar | — | Other | 2,500,000 | $1.25 | $3,125,000 | 22,982,529 | Feb 1, 2022 |
| GMS Ventures & Investments | — | Other | 2,500,000 | $1.25 | $3,125,000 | 27,982,529 | Feb 1, 2022 |
| Dagnon Terry | Chief Operating Officer | Purchase | 25,201 | $1.38 | $34,777 | 1,163,058 | Dec 6, 2021 |
| TRENARY C RUSSELL III | CEO and President | Purchase | 25,000 | $1.39 | $34,750 | 35,000 | Dec 6, 2021 |
| Evanson Jeff | Chief Commercial Officer | Purchase | 35,200 | $1.34 | $47,168 | 1,177,130 | Dec 3, 2021 |
| Dagnon Terry | Chief Operating Officer | Purchase | 10,000 | $1.42 | $14,200 | 1,137,857 | Dec 3, 2021 |
| TRENARY C RUSSELL III | CEO and President | Purchase | 10,000 | $1.40 | $14,000 | 10,000 | Dec 2, 2021 |
| Sukhtian Faisal Ghiath | — | Purchase | 18,000 | $1.40 | $25,200 | 38,000 | Dec 2, 2021 |
| Haddadin Yezan Munther | — | Purchase | 10,000 | $1.39 | $13,900 | 30,000 | Dec 2, 2021 |
| Sukhtian Ghiath M. | — | Purchase | 16,000,000 | $1.25 | $20,000,000 | 27,834,257 | Nov 29, 2021 |
| KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Purchase | 10,000 | $1.83 | $18,300 | 18,926 | Apr 20, 2021 |
| Sukhtian Faisal Ghiath | — | Purchase | 10,000 | $1.82 | $18,200 | 20,000 | Apr 19, 2021 |
| Haddadin Yezan Munther | — | Purchase | 10,000 | $1.82 | $18,200 | 20,000 | Apr 19, 2021 |
| Evanson Jeff | Chief Commercial Officer | Sale | 8,554 | $2.09 | $17,878 | 1,141,930 | Feb 23, 2021 |
| Dagnon Terry | Chief Operating Officer | Sale | 15,900 | $2.09 | $33,231 | 1,127,857 | Feb 23, 2021 |
| Evanson Jeff | Chief Commercial Officer | Sale | 56,973 | $2.55 | $145,281 | 1,150,484 | Feb 12, 2021 |
| Dagnon Terry | Chief Operating Officer | Sale | 63,700 | $2.55 | $162,435 | 1,143,757 | Feb 12, 2021 |
| Sukhtian Ghiath M. | — | Award / Grant | 1,013,627 | $1.00 | $1,013,627 | 11,834,257 | Feb 10, 2021 |
| Syntone Ventures LLC | — | Purchase | 3,000,000 | $1.00 | $3,000,000 | 19,823,045 | Feb 3, 2021 |
| GMS Ventures & Investments | — | Purchase | 8,360,000 | $1.00 | $8,360,000 | 10,820,630 | Feb 2, 2021 |
| Haddadin Yezan Munther | — | Purchase | 10,000 | $0.72 | $7,200 | 10,000 | Sep 22, 2020 |
| Sukhtian Faisal Ghiath | — | Purchase | 10,000 | $0.67 | $6,700 | 10,000 | Sep 17, 2020 |
| THURMAN RANDY H | — | Purchase | 10,000 | $0.62 | $6,200 | 11,875 | Sep 14, 2020 |
| Syntone Ventures LLC | — | Purchase | 823,045 | $1.22 | $1,004,115 | 16,823,045 | Jul 15, 2020 |
| BioLexis Pte Ltd. | — | Option Exercise | 29,358,621 | — | — | 50,965,058 | Mar 23, 2020 |
| Dagnon Terry | Chief Operating Officer | Award / Grant | 1,207,457 | — | — | 1,207,457 | Mar 19, 2020 |
| Evanson Jeff | Chief Commercial Officer | Award / Grant | 1,207,457 | — | — | 1,207,457 | Mar 19, 2020 |